Laporan Laba Rugi COPN - TTM - Cosmo Pharmaceuticals N.V.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Cosmo Pharmaceuticals N.V. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	64	61	62	63	64	65	72	78	90	102	103	104	99	93	139	185	226	267	225	182
Change (%)		-4.63	2.08	2.04	1.25	1.24	10.06	9.14	15.30	13.27	1.05	1.04	-5.50	-5.82	49.89	33.28	21.97	18.01	-15.84	-18.82
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	27	28	28	29	31	33	35	36	38	40	41	42	41	39	41	44	44	45	47	48
Change (%)		1.37	1.72	1.69	7.72	7.16	5.19	4.94	5.61	5.31	2.04	2.00	-3.32	-3.43	5.44	5.16	1.99	1.96	2.67	2.60
% of Revenue	42.63	45.31	45.15	45.00	47.87	50.68	48.44	46.57	42.66	39.66	40.05	40.42	41.36	42.40	29.83	23.53	19.68	17.00	20.74	26.21

Gross Operating Profit	37	33	34	35	34	32	37	42	52	62	62	62	58	53	98	142	182	221	178	134
Change (%)		-9.10	2.38	2.32	-4.04	-4.21	15.06	13.09	23.75	19.19	0.41	0.40	-6.97	-7.50	82.61	45.24	28.11	21.94	-19.63	-24.43
% of Revenue	57.37	54.69	54.85	55.00	52.13	49.32	51.56	53.43	57.34	60.34	59.95	59.58	58.64	57.60	70.17	76.47	80.32	83.00	79.26	73.79

SG&A	21	19	18	17	14	11	12	13	16	20	20	20	29	38	41	45	43	42	41	39
Change (%)		-11.79	-3.41	-3.53	-19.77	-24.64	11.00	9.91	27.83	21.77	0.37	0.36	44.35	30.73	8.58	7.90	-3.34	-3.45	-2.48	-2.54
% of Revenue	33.13	30.65	29.00	27.41	21.72	16.17	16.31	16.42	18.21	19.57	19.44	19.31	29.50	40.94	29.66	24.01	19.03	15.57	18.04	21.66

R&D	14	14	14	14	13	11	11	11	13	15	16	16	18	19	25	30	37	35	34	34
Change (%)		-4.18	0.54	0.54	-8.92	-9.79	0.70	0.69	17.50	14.89	2.25	2.20	9.58	8.74	28.18	21.99	21.42	-5.11	-1.64	-1.67
% of Revenue	22.20	22.31	21.97	21.65	19.47	17.35	15.88	14.65	14.93	15.14	15.32	15.50	17.97	20.74	17.74	16.24	16.16	13.00	15.19	18.40

OpEx	62	59	59	59	57	54	56	59	66	74	76	77	86	95	105	116	121	118	116	114
Change (%)		-4.42	-0.09	-0.09	-4.29	-4.48	4.62	4.42	12.78	11.33	2.12	2.07	11.33	10.18	11.07	9.96	4.54	-2.44	-1.85	-1.88
% of Revenue	96.82	97.04	94.97	92.99	87.90	82.94	78.85	75.44	73.78	72.52	73.28	74.03	87.21	102.02	75.60	62.37	53.46	44.19	51.54	62.30

Operating Income	2	2	3	4	8	11	15	19	24	28	28	27	13	-2	34	70	105	149	109	69
Change (%)		-11.11	73.30	42.30	74.70	42.76	36.48	26.73	23.06	18.74	-1.76	-1.79	-53.46	-114.88	-1,910.03	105.52	50.84	41.50	-26.92	-36.84
% of Revenue	3.18	2.96	5.03	7.01	12.10	17.06	21.15	24.56	26.22	27.48	26.72	25.97	12.79	-2.02	24.40	37.63	46.54	55.81	48.46	37.70

Interest Expense	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9	-6	-4	-2	-0	-0	-0
Change (%)		0.73	0.76	0.76	0.69	0.69	0.78	0.78	0.15	0.15	-0.27	-0.27	-3.20	-3.31	-26.44	-35.95	-49.34	-97.40	34.91	25.87
% of Revenue	-13.57	-14.33	-14.14	-13.97	-13.89	-13.82	-12.65	-11.68	-10.15	-8.97	-8.85	-8.74	-8.95	-9.19	-4.51	-2.17	-0.90	-0.02	-0.03	-0.05

Net Income	-7	-8	-9	-11	6	22	28	35	26	17	14	11	0	-11	24	59	94	133	97	60
Change (%)		8.03	17.25	14.71	-151.97	292.43	31.40	23.90	-25.59	-34.39	-18.53	-22.75	-99.74	-37,935.09	-323.44	144.75	58.94	42.15	-27.49	-37.91
% of Revenue	-11.44	-12.96	-14.89	-16.74	8.59	33.30	39.76	45.14	29.13	16.87	13.60	10.40	0.03	-11.62	17.32	31.81	41.46	49.94	43.03	32.91

Source: Capital IQ

GB:COPNZ
US:CMOPF
DE:C43	€ 69.50
GB:0RGI	CHF 65.50
CH:COPN	CHF 65.60

Cosmo Pharmaceuticals N.V. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings